NCT04876521View on ClinicalTrials.gov

Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

June 9, 2021

Study Completion Date

June 30, 2021

Conditions
Post-Schizophrenic Depression
Interventions
DRUG

Amisulpride

low dose of Amisulpride at 100-300 mg/day

DRUG

Olanzapine-Fluoxetine Combination

Olanzapine (5-10 mg/day) and Fluoxetine (20 mg/day)

Trial Locations (1)

DR BISWA RANJAN MISHRA

All India Institute of Medical Sciences, Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT04876521 - Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression | Biotech Hunter | Biotech Hunter